In the Addressing the Impact of RSV and Vaccine Hesitancy educational series, we explore the efficacy of RSV vaccines and discuss preventive strategies aimed at reducing the occurrence of severe RSV respiratory illness in infants, children, and older adults. Listen to insightful expert interviews via Podcast covering timely and timeless topics on RSV and Vaccine Hesitancy.
Podcasts
Release date: July 27, 2024
Expiration date: July 23, 2026
Estimated Time: 30 minutes
Type: Podcast
Technical Requirements: none
Specialty: infectious disease, internal medicine, nursing , women’s health, pediatrics, pharmacy, family practice, pulmonology
Release date: July 10, 2024
Expiration date: July 9, 2025
Estimated Time: 35 minutes
Type: Podcast
Technical Requirements: none
Specialty: infectious disease, internal medicine, nursing , women’s health, pediatrics, pharmacy, family practice, pulmonology
Release date: June 26, 2024
Expiration date: June 25, 2025
Estimated Time: 40 minutes
Type: Podcast
Technical Requirements: none
Specialty: infectious disease, internal medicine, nursing , women’s health, pediatrics, pharmacy, family practice, pulmonology
Release date: May 22, 2024
Expiration date: May 21, 2025
Estimated Time: 45 minutes
Type: Podcast
Technical Requirements: none
Specialty: infectious disease, internal medicine, nursing , women’s health, pediatrics, pharmacy, family practice, pulmonology
Release date: May 8, 2024
Expiration date: May 7, 2025
Estimated Time: 40 minutes
Type: Podcast
Technical Requirements: none
Specialty: infectious disease, internal medicine, nursing , women’s health, pediatrics, pharmacy, family practice, pulmonology
Release date: April 10, 2024
Expiration date: April 9, 2026
Estimated Time: 30 minutes
Type: Podcast
Technical Requirements: none
Specialty: infectious disease, internal medicine, nursing , women’s health, pediatrics, pharmacy, family practice, pulmonology
Release date: March 13, 2024
Expiration date: March 12, 2026
Estimated Time: 30 minutes
Type: Podcast
Technical Requirements: none
Specialty: infectious disease, internal medicine, nursing , women’s health, pediatrics, pharmacy, family practice, pulmonology
Release date: February 14, 2024
Expiration date: February 13, 2026
Estimated Time: 30 minutes
Type: Podcast
Technical Requirements: none
Specialty: infectious disease, internal medicine, nursing , women’s health, pediatrics, pharmacy, family practice, pulmonology
Non-CE Podcast
Estimated Time: 30 minutes
Type: Podcast
Technical Requirements: none
Specialty: infectious disease, internal medicine, nursing , women’s health, pediatrics, pharmacy, family practice, pulmonology
Target Audience
Geriatricians, infection disease physicians, intensivists, nurse practitioners, nurses, obstetricians/gynecologists, pediatricians, pharmacists, physician assistants, primary care physicians, pulmonologists, and other prescribing and non-prescribing providers
Cleveland Clinic Planning Committee
Cecile Foshee, PhD
Co-Activity Director
Director, Office of Interprofessional Learning
Steven Gordon, MD
Co-Activity Director
Chairman, Infectious Disease Department
Kaitlyn Rivard, PharmD
Co-Activity Director
Department of Pharmacy
Nichole Brown, MSN, RN, CHSE-A, PhD(c )
Nursing Institute
Neal Chaisson, MD
Department of Critical Care Medicine
Department of Pulmonary Medicine
Frank Esper, MD
Pediatric Infectious Disease
Cleveland Clinic Children’s Hospital
Debra Kangisser, PA-C
Director of Education
Physician Assistant Services
Aanchal Kapoor, MD, Med
Department of Critical Care Medicine
Department of Pulmonary Medicine
Steven Kawczak, PhD, CHCP, FACEHP
Co-Medical Director, Center for Continuing Education
Neil Mehta, MBBS, MS
Center for Technology-Enhanced
Knowledge and Instruction
Associate Dean of Curricular Affairs, Cleveland Clinic Lerner College of
Medicine
Anne Vanderbilt, APRN
Senior Director, Advance Nursing Practices
Center for Geriatric Medicine
Hannah Wang, MD
Director, Molecular Microbiology & Virology
Acknowledgment
The Cleveland Clinic Center for Continuing Education acknowledges an educational grant for support of this activity from ModernaTX, Inc.